TRAVAMULSION 10% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Travamulsion 10%, and what generic alternatives are available?
Travamulsion 10% is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in TRAVAMULSION 10% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
Summary for TRAVAMULSION 10%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TRAVAMULSION 10% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRAVAMULSION 10%
US Patents and Regulatory Information for TRAVAMULSION 10%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | TRAVAMULSION 10% | soybean oil | INJECTABLE;INJECTION | 018660-001 | Feb 26, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
